Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline

Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline

Objective: Therapy-related myeloid neoplasms (t-MN) account for approximately 10% to 20% of all cases of AML (acute myeloid leukemia), MDS (myelodysplastic syndrome) and MDS/MPN (myelodysplastic syndrome/myeloproliferative neoplasms), MDS, and MDS/MPN. In our study, we evaluated peripheral blood sme...

Full description

Bibliographic Details
Main Authors: Hasan Mutlu, Zeki Akca, Havva Uskudar Teke, Hediye Ugur
Format: Article
Language:English
Published: AVES 2011-12-01
Series:Eurasian Journal of Medicine
Subjects:
Anthracycline
Breast cancer
Chemotherapy side effect
Leukemia
Myelodysplasia
Online Access:http://www.eajm.org/text.php3?id=411

Internet

http://www.eajm.org/text.php3?id=411

Similar Items